306 related articles for article (PubMed ID: 22767382)
1. Non-demyelinating, reversible conduction failure in Fisher syndrome and related disorders.
Umapathi T; Tan EY; Kokubun N; Verma K; Yuki N
J Neurol Neurosurg Psychiatry; 2012 Sep; 83(9):941-8. PubMed ID: 22767382
[TBL] [Abstract][Full Text] [Related]
2. Miller Fisher syndrome, Bickerstaff brainstem encephalitis and Guillain-Barré syndrome overlap with persistent non-demyelinating conduction blocks: a case report.
Puma A; Benoit J; Sacconi S; Uncini A
BMC Neurol; 2018 Jul; 18(1):101. PubMed ID: 30031375
[TBL] [Abstract][Full Text] [Related]
3. Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies.
Kimoto K; Koga M; Odaka M; Hirata K; Takahashi M; Li J; Gilbert M; Yuki N
Neurology; 2006 Nov; 67(10):1837-43. PubMed ID: 17130419
[TBL] [Abstract][Full Text] [Related]
4. Motor and sensory conduction failure in overlap of Guillain-Barré and Miller Fisher syndrome: two simultaneous cases.
Rajabally YA; Hassan-Smith G; Notturno F; Eames PJ; Hayton T; Capasso M; Uncini A
J Neurol Sci; 2011 Apr; 303(1-2):35-8. PubMed ID: 21316711
[TBL] [Abstract][Full Text] [Related]
5. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
[TBL] [Abstract][Full Text] [Related]
6. Prediction of disease progression in Miller Fisher and overlap syndromes.
Verboon C; van Berghem H; van Doorn PA; Ruts L; Jacobs BC
J Peripher Nerv Syst; 2017 Dec; 22(4):446-450. PubMed ID: 29065229
[TBL] [Abstract][Full Text] [Related]
7. How often and when Fisher syndrome is overlapped by Guillain-Barré syndrome or Bickerstaff brainstem encephalitis?
Sekiguchi Y; Mori M; Misawa S; Sawai S; Yuki N; Beppu M; Kuwabara S
Eur J Neurol; 2016 Jun; 23(6):1058-63. PubMed ID: 26969889
[TBL] [Abstract][Full Text] [Related]
8. Anti-GQ1b IgG antibody syndrome: clinical and immunological range.
Odaka M; Yuki N; Hirata K
J Neurol Neurosurg Psychiatry; 2001 Jan; 70(1):50-5. PubMed ID: 11118247
[TBL] [Abstract][Full Text] [Related]
9. Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy.
Créange A; Shahrizaila N; Salhi H; Lefaucheur JP; Yuki N
J Peripher Nerv Syst; 2014 Jun; 19(2):115-20. PubMed ID: 24750296
[TBL] [Abstract][Full Text] [Related]
10. Reversible conduction failure in overlap of Miller Fisher syndrome and pharyngeal-cervical-brachial variant of Guillain-Barré syndrome in the spectrum of nodo-paranodopathies.
Gürsoy AE; Kolukısa M; Babacan-Yıldız G; Altıntaş Ö; Yaman A; Asil T
J Clin Neurosci; 2014 Jul; 21(7):1269-71. PubMed ID: 24534627
[TBL] [Abstract][Full Text] [Related]
11. Serial nerve conduction studies provide insight into the pathophysiology of Guillain-Barré and Fisher syndromes.
Shahrizaila N; Goh KJ; Kokubun N; Abdullah S; Yuki N
J Neurol Sci; 2011 Oct; 309(1-2):26-30. PubMed ID: 21849173
[TBL] [Abstract][Full Text] [Related]
12. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
[TBL] [Abstract][Full Text] [Related]
13. Anti-ganglioside complex antibody profiles in a recurrent complicated case of GQ1b-seronegative miller fisher syndrome and Bickerstaff brainstem encephalitis: a case report.
Ito H; Hatanaka Y; Fukami Y; Harada Y; Kobayashi R; Okada H; Uchibori A; Chiba A; Okuda S
BMC Neurol; 2018 May; 18(1):72. PubMed ID: 29792178
[TBL] [Abstract][Full Text] [Related]
14. Electrodiagnosis of reversible conduction failure in Guillain-Barré syndrome.
Chan YC; Punzalan-Sotelo AM; Kannan TA; Shahrizaila N; Umapathi T; Goh EJH; Fukami Y; Wilder-Smith E; Yuki N
Muscle Nerve; 2017 Nov; 56(5):919-924. PubMed ID: 28093784
[TBL] [Abstract][Full Text] [Related]
15. Clinical correlates of serum anti-GT1a IgG antibodies.
Nagashima T; Koga M; Odaka M; Hirata K; Yuki N
J Neurol Sci; 2004 Apr; 219(1-2):139-45. PubMed ID: 15050449
[TBL] [Abstract][Full Text] [Related]
16. Nationwide survey of childhood Guillain-Barré syndrome, Fisher syndrome, and Bickerstaff brainstem encephalitis in Japan.
Fujii K; Shiohama T; Uchida T; Ikehara H; Fukuhara T; Sawada D; Aoyama H; Uchikawa H; Yoshii S; Arahata Y; Shimojo N; Misawa S; Kuwabara S
Brain Dev; 2023 Jan; 45(1):16-25. PubMed ID: 36511273
[TBL] [Abstract][Full Text] [Related]
17. Demyelinating Guillain-Barré syndrome recurs more frequently than axonal subtypes.
Notturno F; Kokubun N; Sekiguki Y; Nagashima T; De Lauretis A; Yuki N; Kuwabara S; Uncini A
J Neurol Sci; 2016 Jun; 365():132-6. PubMed ID: 27206890
[TBL] [Abstract][Full Text] [Related]
18. Non-demyelinating, reversible conduction failure in a case of pharyngeal-cervical-brachial weakness overlapped by Fisher syndrome.
Chan YC; Ahmad A; Paliwal P; Yuki N
J Neurol Sci; 2012 Oct; 321(1-2):103-6. PubMed ID: 22868091
[TBL] [Abstract][Full Text] [Related]
19. Pitfalls in electrodiagnosis of Guillain-Barré syndrome subtypes.
Uncini A; Manzoli C; Notturno F; Capasso M
J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1157-63. PubMed ID: 20870864
[TBL] [Abstract][Full Text] [Related]
20. An antibody to the GM1/GalNAc-GD1a complex correlates with development of pure motor Guillain-Barré syndrome with reversible conduction failure.
Ogawa G; Kaida K; Kuwahara M; Kimura F; Kamakura K; Kusunoki S
J Neuroimmunol; 2013 Jan; 254(1-2):141-5. PubMed ID: 23000056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
